Australian scientists are helping to develop a new way to determine which mental health drugs are best for patients based on their metabolic profile.
Led by Prof. Sean Hood, the head of University of Western Australia’s (UWA) School of Psychiatry, and working in combination with U.S. mental health technology company Prairie Health, the study will evaluate how genetics impacts the type of medication chosen to treat anxiety disorders.
Prairie Health, a California based company that assists people with anxiety and mood disorders to get personalised mental health care, is pioneering the routine use of genetic profiles of metabolic pathways to guide which antidepressants are most suited to individual patients.
…